{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-005495","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.053982+00:00","generated_at":"2026-05-26T01:03:03.510965+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"LeMaitre Q4 sales $55.7M (+14%), EPS $0.49 (+30%), raises dividend 25%","bullets":["Q4 sales $55.7M (+14% organic), EPS $0.49 (+30%), op income $12.9M (+26%).","Quarterly dividend increased 25% to $0.20/share, payable March 27 to March 13 record date.","Board authorized $75M share repurchase program through Feb 2026.","Issued $172.5M 2.50% convertible notes due 2030 in Dec 2024, net proceeds $167.7M.","FY2025 guidance: sales $239.1M mid (+9%, +10% organic), EPS $2.24 mid (+16%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-005495","json":"https://secwatch.observer/filing/0001437749-25-005495.json","markdown":"https://secwatch.observer/filing/0001437749-25-005495.md","text":"https://secwatch.observer/filing/0001437749-25-005495.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925005495/0001437749-25-005495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774925005495/lmat20250227_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:03:03.510965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}